Nine PDUFA dates on FDA’s November roster
Decisions include the first vaccine for Chikungunya and three new cancer therapies
FDA has scheduled PDUFA dates in November for at least nine applications, including NDAs for three new cancer therapies and a BLA for what could become the first Chikungunya vaccine.
All three cancer candidates on FDA’s roster are under priority review. ...
BCIQ Company Profiles